Trial Profile
Study of Sci-B-Vac in patients with end-stage renal disease (ESRD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 06 Oct 2016 New trial record
- 21 Sep 2016 Results published in VBI Vaccines media release.